(INNS)
AKRIXOLIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-441) [VH (HOMO SAPIENS IGHV3-30*01 (95.8%) -(IGHD) - IGHJ5*01 (100%), CDR-IMGT [8.8.7] (26-33.51-58.97- 103)) (1-114)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (115-212), HINGE 1-12 S10>P (222) (213-224), CH2 (225-334), CH3 (335-439), CHS (440-441)) (115- 441)], (128-220')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-220') [V-KAPPA (HOMO SAPIENS IGKV2- 40*01 (94.1%) -IGKJ3*01 (91.7%) P120>Q (106), CDR-IMGT [12.3.9] (27-38.56-58.95-103)) (1'-113') - HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159), V101 (197) (114'-220')]; DIMER (220-220'':223-223'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA(WHO)
ACRIXOLIMABUM(INN)